迈得医疗股价涨5.79%，浙商证券资管旗下1只基金重仓，持有4.3万股浮盈赚取4.86万元

Group 1 - The core viewpoint of the news is the performance and market position of Maide Medical, which saw a stock price increase of 5.79% to 20.66 CNY per share, with a total market capitalization of 3.434 billion CNY [1] - Maide Medical, established in March 2003 and listed in December 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue composition of Maide Medical includes: 42.18% from safety infusion line machines, 37.90% from blood purification line machines, 14.04% from safety infusion single machines, and 5.87% from other categories [1] Group 2 - According to data from the top ten heavy stocks of funds, a fund under Zheshang Securities Asset Management holds a significant position in Maide Medical, with 43,000 shares, accounting for 2.79% of the fund's net value [2] - The Zheshang Huijin New Consumption Fund (009527) has achieved a year-to-date return of 18.39% and a one-year return of 53.15%, ranking 4505 out of 8174 and 2837 out of 7982 respectively [2] - The fund manager, Chen Gujun, has been in position for 5 years and 241 days, with the fund's total asset size at 204 million CNY [3]